Home › Funds › Opaleye Management Inc. › EWTX

Opaleye Management Inc. position in EWTX

EDGEWISE THERAPEUTICS INC · Health Care

Opaleye Management Inc. reported holding 500,000 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$20.3M, representing 1.84% of its reported portfolio and ranking #15 among its reported holdings. Opaleye Management Inc. has disclosed EWTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)500.00K sh
Reported value held$20.32M
Portfolio Weight1.84%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Opaleye Management Inc.'s EWTX position evolved

Opaleye Management Inc. first disclosed a stake in EWTX in Q3 2023 at 875,405 shares (US$5.0M). The position peaked in Q2 2026 at 500,000 shares, worth US$20.3M. Across 12 filings, Opaleye Management Inc. increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 500,000 shares valued at US$20.3M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 875.40K $5.02M New
Q4 2023 699.00K $7.65M Reduce
Q1 2024 665.00K $12.13M Reduce
Q2 2024 580.00K $10.45M Reduce
Q3 2024 522.50K $13.95M Reduce
Q4 2024 480.00K $12.82M Reduce
Q1 2025 395.00K $8.69M Reduce
Q2 2025 490.00K $6.42M Add
Q3 2025 500.00K $8.11M Add
Q4 2025 500.00K $12.41M Hold
Q1 2026 500.00K $15.75M Hold
Q2 2026 500.00K $20.32M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EWTX and 13F data

EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EWTX

All EWTX fund holders →

FAQ

How long has Opaleye Management Inc. held EWTX?

Opaleye Management Inc. has disclosed EWTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Opaleye Management Inc.'s current position in EWTX?

As of Q2 2026, Opaleye Management Inc. holds 500.00K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $20.32M, representing 1.84% of its reported portfolio and ranking #15.

Has Opaleye Management Inc. been buying or selling EWTX?

In the latest 13F filing (Q2 2026), Opaleye Management Inc. held unchanged its position in EWTX. The position peaked in Q2 2026 at 500.00K shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.